In Genome Research this week: copy number variant analysis of Anopheles gambiae, comparison of approaches to predict transcription factor activity, and more.
By analyzing metagenomic sequences found in thousands of human mouth and gut samples, researchers tracked down almost 45.7 million distinct microbial genes.
The FDA center of excellence has engaged the technology vendor to incorporate real-world evidence into regulatory decision-making for precision oncology treatments.
The firm reported total revenues of $215.4 million, up from $193.9 million in fiscal Q4 2018, but below the consensus Wall Street estimate of $221.0 million.
The firm brought in $15.8 million during the quarter compared to $8.8 million a year ago, and beating Wall Street expectations.
The firm offered more than 2.7 million shares of its common stock, including 356,435 shares to its underwriters pursuant to an option to purchase additional shares.
The Cancer Journal documented 25 cases where inappropriate tests were ordered, variants were interpreted incorrectly, and wrong results were reported to patients.
Two Utah cases represent the promise and pitfalls of using genetic genealogy in law enforcement, the Salt Lake Tribune reports.
The Wall Street Journal reports that patients might be unaware of hospitals' exclusive agreements with drugmakers for access to genetic data.
The New York Times writes that genes may influence when people prefer to sleep.
The Wall Street Journal looks into FamilyTreeDNA's handling of genetic genealogy searches by law enforcement.
In a point-counterpoint in the Boston Globe, researchers discuss the potential of gene editing to prevent Lyme disease, but also the pitfalls of doing so.
MIT's Technology Review reports that researchers hope to develop a CRISPR-based pain therapy.
In Science this week: atlas of malaria parasites' gene expression across their life cycles, and more.